Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case–control study

Purpose: Patients with osteoporosis are at an increased risk of cardiovascular disease (CVD). Several antiosteoporosis medications have been demonstrated with the benefit of preventing osteoporosis. Our aim is to assess the CVD risks associated with antiosteoporosis medications using the National He...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Wen-Hsuan, Sung, Fung-Chang, Muo, Chih-Hsin, Tsai, Ming-Chieh, Wu, Shu-I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595014/
https://www.ncbi.nlm.nih.gov/pubmed/37881187
http://dx.doi.org/10.3389/fphar.2023.1220174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595014/
https://www.ncbi.nlm.nih.gov/pubmed/37881187
http://dx.doi.org/10.3389/fphar.2023.1220174

Ejemplares similares